Eicosapentaenoic Acid and Oxypurinol in the Treatment of Muscle Wasting in a Mouse Model of Cancer Cachexia

PLoS ONE - United States
doi 10.1371/journal.pone.0045900
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Targeting RAGE Prevents Muscle Wasting and Prolongs Survival in Cancer Cachexia

Journal of Cachexia, Sarcopenia and Muscle
OrthopedicsSports MedicinePhysiology
2020English

Pathogenesis of Muscle Wasting in Cancer Cachexia: Targeted Anabolic and Anticatabolic Therapies

Current Opinion in Clinical Nutrition and Metabolic Care
MedicineNutritionDietetics
2010English

Myostatin: Regulator of Muscle Wasting in Heart Failure and Treatment Target for Cardiac Cachexia

Circulation
Cardiovascular MedicinePhysiologyCardiology
2010English

The Countermeasure for Cancer Cachexia Related Muscle Wasting Does Not Need to Be Muscle Hyperplasia

Acta Physiologica
Physiology
2019English

Eicosapentaenoic Acid as Adjuvant for Cachexia in Cancer’s Patients

International Journal of Integrated Health Sciences
2015English

Skeletal Muscle Mitochondrial Uncoupling in a Murine Cancer Cachexia Model

International Journal of Oncology
Cancer ResearchOncology
2013English

TLR/MyD88/XBP1 Signaling Axis Mediates Skeletal Muscle Wasting During Cancer Cachexia

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2019English

The Tissue Uptake of [14C] Eicosapentaenoic Acid in a Mouse

Nippon Suisan Gakkaishi
Aquatic Science
1981English

MicroRNA-mRNA Co-Sequencing Identifies Transcriptional and Post-Transcriptional Regulatory Networks Underlying Muscle Wasting in Cancer Cachexia

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy